When John Cantrell retired, he decided his new job would be staying healthy. He was already in good shape and ate well but he wanted to make sure he could see his grandkids grow up. Already an avid ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device ...

Please provide your email address to receive an email when new articles are posted on . Self-expanding TAVR was linked to lower valve gradient at rest and during exercise vs. balloon-expandable valves ...

SPONSORED — Transcatheter Aortic Valve Replacement (TAVR) is reshaping the way physicians treat severe aortic stenosis—a dangerous narrowing of the aortic valve that restricts blood flow and forces ...

Edwards Lifesciences (EW) grew TAVR sales 12.4% to $1.15B while Boston Scientific (BSX) exited TAVR entirely for cardiovascular diversification. Boston Scientific’s operating income surged 384.5% to ...

At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic ...

Add Yahoo as a preferred source to see more of our stories on Google. Edwards Lifesciences' Sapien 3 Ultra system. The artificial heart valve is pushed through the blood vessels via a catheter and ...

In December, Edwards Lifesciences persuaded CMS to publish an updated tracking sheet for TAVR national coverage analysis, causing the agency to reconsider its previous stance on covering transcatheter ...

Medtronic has plans to purchase $90 million worth of shares in Anteris Technologies Global, a company that specializes in the development of transcatheter aortic valve replacement devices. Medtronic’s ...

JP Morgan upgraded Edwards Lifesciences (EW) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replacement (TAVR) division and strength in its transcatheter ...

SAN FRANCISCO — After 7 years, transcatheter aortic valve replacement (TAVR) remains equivalent to surgery with respect to durability and safety in low-risk patients, a finding that may blunt ...

Add Yahoo as a preferred source to see more of our stories on Google. Edwards Lifesciences’ transcatheter aortic valve replacement (TAVR) system has demonstrated positive results in a long-term trial ...